Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant

Liang Gao1, Kunwei Shen2, Ni Yin3

  • 1Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.

Frontiers in Oncology
|December 16, 2020
PubMed
Abstract

Insights

This study profiles non-coding RNAs (ncRNAs) in endocrine-resistant breast cancer cells, revealing their role in tamoxifen and fulvestrant resistance. Findings offer new biomarkers and therapeutic targets for overcoming resistance.

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • Hormone receptor-positive breast cancer treatment relies on tamoxifen and fulvestrant.
  • Acquired resistance to endocrine therapy limits treatment efficacy.
  • Non-coding RNAs (ncRNAs) are implicated in endocrine resistance, but their specific roles are unclear.

Purpose of the Study:

  • To comprehensively profile ncRNAs in tamoxifen- and fulvestrant-resistant breast cancer cells.
  • To investigate the role of ncRNAs in acquired endocrine resistance.
  • To identify potential biomarkers and therapeutic targets for overcoming endocrine resistance.

Main Methods:

  • Microarray analysis of endocrine-sensitive and resistant breast cancer cell lines (MCF-7, LCC2, LCC9).
  • Gene ontology and pathway analysis for functional prediction of differentially expressed ncRNAs.
  • Construction of competing endogenous RNA (ceRNA) regulatory networks (lncRNA-mRNA, circRNA-mRNA, microRNA-mRNA, and integrated networks).

Main Results:

  • Identified significant differential expression of 3,129 long non-coding RNAs (lncRNAs), 13,556 circular RNAs (circRNAs), 132 microRNAs, and 3,358 messenger RNAs (mRNAs).
  • Constructed co-expression and regulatory networks (lncRNA-microRNA-mRNA, circRNA-microRNA-mRNA) to illustrate ncRNA crosstalk and transcriptomic regulation.
  • Detailed ncRNA profiles in endocrine-resistant cells were established.

Conclusions:

  • Provides a comprehensive ncRNA profile in tamoxifen- and fulvestrant-resistant breast cancer.
  • Enhances understanding of the mechanisms underlying endocrine resistance.
  • Highlights potential novel biomarkers and therapeutic strategies to combat endocrine resistance in breast cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.8K